Related Experiment Video
Updated: Aug 19, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
A role for EMT in CD73 regulation in breast cancer
Meriem Hasmim1, Guy Berchem1,2, Bassam Janji1
1Tumor Immunotherapy and Microenvironment Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg.
Abstract:
CD73 is an emerging target in cancer due to its role in generating adenosine, a potent immunosuppressor. We found that SNAI1, a driver of epithelial-to-mesenchymal transition (EMT), upregulates CD73 in triple negative breast cancer cells. Here, we discuss the relevance of improving CD73-based therapy by combining with inhibitors of EMT.
Related Concept Videos
Mitogens and the Cell Cycle
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Master Transcription Regulators

